Trans Fatty Acid and Coronary Disease: The Debate Continues. 3. What Should We Tell Consumers?

American Journal of Public Health - United States
doi 10.2105/ajph.85.3.411
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Public Health Association

Related search

Trans Fatty Acid and Coronary Disease: The Debate Continues. 1. The Use of Population Attributable Risk.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1995English

Trans Fatty Acid and Coronary Disease: The Debate Continues. 2. Confounding and Selection Bias in the Data.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1995English

What Should We Tell Patients With Heart Failure About Sodium Restriction and How Should We Counsel Them?

Current Heart Failure Reports
Emergency MedicineCardiovascular MedicinePhysiologyCardiology
2013English

The Optimal Revascularization Strategy for Multivessel Coronary Artery Disease: The Debate Continues.

Cleveland Clinic Journal of Medicine
Medicine
2006English

The Debate Continues

Nature
Multidisciplinary
1988English

Intubation and Mechanical Ventilation of Patients With COVID-19: What Should We Tell Them?

Monaldi Archives for Chest Disease
Cardiovascular MedicinePulmonaryRespiratory MedicineCardiology
2020English

The Debate Continues

Nature
Multidisciplinary
1988English

Atherosclerosis and Lupus: What We Know and What We Should Know

Journal of Rheumatology
RheumatologyAllergyImmunology
2009English

AIDS Debate Continues

Nature
Multidisciplinary
1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy